Glucose-insulin-potassium solution before cardiopulmonary bypass in coronary artery surgery;Koroner arter cerrahisinde kardiyopulmoner bypass oncesi glukoz-insulin-potasyum solusyonu

Turk Anesteziyoloji ve Reanimasyon

Volumn 28, Issue 7, 2000, Pages 361-365

  Turkoz, A ^a   Toprak, H I ^a   Sari, S ^a   Ozturk, E ^a   Durmus, M ^a   Turkoz, R ^a   Ersoy, M O ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Coronary artery bypass grafting; Glucose; Insulin; Potassium

Indexed keywords

ANESTHETIC AGENT; DIAZEPAM; ETOMIDATE; FENTANYL; GLUCOSE; INSULIN; NEUROMUSCULAR BLOCKING AGENT; POTASSIUM; VECURONIUM;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; HEMODYNAMIC PARAMETERS; HUMAN; METABOLIC PARAMETERS; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0033784354     PISSN: 10165150     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction
2. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion
3. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement
4. Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failer after aortocoronary bypass surgery
5. Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting
6. Glucose and insulin supply before cardiopulmonary bypass in cardiac surgery: A double-blind study
7. Metabolic modulation of acute myocardial infarction: The ECLA glucose-insulin-potassium pilot trial
8. Miyokard revaskulerizasyonunda anterograd kardiyopleji ile anterograd+retrograd kardioplejinin karsilastirilmasi
9. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction
10. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions
11. Myocardial protection during ischemic cardiac arrest: Possible deleterious effects of glucose and mannitol in coronary infusates
12. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction: Relation to myocardial ischemia and infarct size
13. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction
14. Frontiers of therapy: Use of glucose-insulin-potassiumin treating myocardial infarction
15. Is there a rationale for glucose-insulin-potassium therapyin acute myocardial infarction?
16. Exogenous glucose utilization is superior to glycogenolysis at preserving cardiac function during hypoxia
17. Effects of glucose and fatty acids on myocardia ischaemia and arrhythmias
18. Depression of myocardial contractility in rats by free fatty acids during hypoxia
19. Inhibition by stimulated ischemia or hypoxia of delayed after depolarizations provoked by cyclic AMP: Significance for ischaemic and reperfusion arrhythmias
20. Relation between serum free fatty acids and arrhythmias and death after acute myocardial infarction
21. A metabolic cause of arrhythmias during acute myocardial hypoxia
22. Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction
23. Insulin improves post-ischemic recovery and glucose metabolism in the working rat heart perfused with oleate
24. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials
25. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting
26. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support